Search
for

    Sort by

    Research 331–360 of 540

    1. Modulation of genomic and postgenomic alterations in noncancer diseases and critical periods of life Mutation research · 2008 · 9 citations
    2. IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA Zenodo (CERN European Organization for Nuclear Research) · 2023
    3. Hedgehog signalling in skin development and cancer Experimental Dermatology · 2006 · 190 citations
    4. Primärprävention urologischer Tumore: Prostatakarzinom Der Urologe · 2011 · 2 citations
    5. Feeding the skin: The emerging role of nutritional intervention in dermatological disorders 2026
    6. Putting it all together: How do primary care physicians interpret and use the results of prevention trials? Cancer Epidemiology and Prevention Biomarkers · 2006
    7. Chemoprävention des Prostatakarzinoms - Ein Plädoyer Aktuelle Urologie · 2012 · 1 citations
    8. Chemopr�vention des Prostatakarzinoms Der Urologe · 2004 · 12 citations
    9. Louisiana Marinas and Boat Launches, LOSCO (2003) [marinas] Urologia Internationalis · 2003 · 1 citations
    10. Pertinence d’une chimioprévention à partir de l’étude PCPT Progrès en Urologie · 2008 · 1 citations
    11. Finasteride for prostatic disease: an updated and comprehensive review Expert opinion on drug metabolism & toxicology · 2008 · 14 citations
    12. Phytotherapeutic Molecules & Antioxidants: A Novel & Secure Approach of Cancer Prevention Annual Research & Review in Biology · 2015
    13. Editorial comment The Journal of Urology · 2006
    14. 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times? Cancer Epidemiology, Biomarkers & Prevention · 2022 · 1 citations
    15. The role of multicultural festivals in a society in transition: From being ethnically homogeneous to becoming multicultural 2012
    16. Analytical methods of dutasteride: An overview Annals of phytomedicine · 2023
    17. Skin Cancer: Mechanisms and Human Relevance Medical Entomology and Zoology · 1994 · 213 citations
    18. The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review Consilium Medicum · 2025
    19. Abstract 5357: Targeting mTORC1 suppresses proliferation of keratinocyte stem cells and inhibits skin tumor promotion in mice Cancer research · 2014
    20. Finasteride Expert Opinion on Drug Metabolism & Toxicology · 2010 · 10 citations
    21. Abstract 5561: 20(S)-Protopanaxadiol-aglycone downregulates full-length and ligand-independent splice variants of androgen receptor Cancer Research · 2011
    22. Regarding prostate-specific antigen: let's not shoot the messenger QJM · 2011 · 3 citations
    23. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. PubMed · 2002 · 143 citations
    24. α‐Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo‐prevention International Journal of Dermatology · 2006 · 9 citations
    25. 5 Alpha-reductase inhibitors: whatʼs new? Current opinion in urology · 2003 · 47 citations
    26. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    27. Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata 2015
    28. Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro Americanae (AECID Library) · 2013
    29. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects The Journal of Sexual Medicine · 2012 · 35 citations
    30. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations